See more : Andrew Peller Limited (ADWPF) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang Medicine Co., Ltd. (600216.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Medicine Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Okuwa Co., Ltd. (8217.T) Income Statement Analysis – Financial Results
- Kissei Pharmaceutical Co., Ltd. (KSPHF) Income Statement Analysis – Financial Results
- Hutchison Telecommunications (Australia) Limited (HTA.AX) Income Statement Analysis – Financial Results
- Bystronic AG (BYS.SW) Income Statement Analysis – Financial Results
- Toutabo SA (MLABO.PA) Income Statement Analysis – Financial Results
Zhejiang Medicine Co., Ltd. (600216.SS)
About Zhejiang Medicine Co., Ltd.
Zhejiang Medicine Co., Ltd. produces and sells life nutrition and pharmaceutical products in China. The company offers life nutrition products, such as synthetic vitamin E, vitamin A, natural vitamin E, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, lycopene, and other vitamins and vitamin products. It also provides pharmaceutical manufacturing products, including anti-drug resistant antibiotics, anti-malaria and other pharmaceutical raw materials, quinolones, and anti-drug resistant products; and pharmaceutical products comprising sugars and hormones. The company was founded in 1997 and is headquartered in Shaoxing, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.79B | 8.12B | 9.13B | 7.33B | 7.04B | 6.86B | 5.69B | 5.28B | 4.50B | 4.83B | 4.93B | 5.26B | 4.83B | 4.56B | 4.18B | 3.76B | 2.21B | 2.20B | 1.88B | 1.38B | 1.13B | 1.11B | 867.04M | 1.08B | 1.19B | 1.09B | 915.02M | 763.56M |
Cost of Revenue | 5.27B | 5.32B | 5.40B | 4.28B | 4.17B | 3.98B | 4.00B | 3.78B | 3.74B | 3.79B | 3.68B | 3.62B | 3.02B | 2.67B | 2.29B | 2.08B | 1.86B | 1.82B | 1.51B | 1.19B | 983.65M | 863.90M | 648.14M | 799.93M | 872.97M | 857.60M | 736.27M | 630.86M |
Gross Profit | 2.52B | 2.80B | 3.73B | 3.04B | 2.87B | 2.88B | 1.69B | 1.50B | 753.07M | 1.04B | 1.25B | 1.65B | 1.81B | 1.89B | 1.89B | 1.68B | 344.98M | 376.50M | 373.71M | 188.34M | 149.24M | 249.50M | 218.90M | 277.63M | 315.69M | 235.41M | 178.75M | 132.70M |
Gross Profit Ratio | 32.39% | 34.47% | 40.85% | 41.54% | 40.76% | 41.93% | 29.66% | 28.37% | 16.75% | 21.50% | 25.32% | 31.26% | 37.49% | 41.37% | 45.22% | 44.57% | 15.62% | 17.14% | 19.83% | 13.62% | 13.17% | 22.41% | 25.25% | 25.76% | 26.56% | 21.54% | 19.54% | 17.38% |
Research & Development | 860.07M | 809.28M | 806.86M | 546.09M | 450.42M | 321.56M | 257.55M | 217.78M | 180.58M | 215.68M | 192.01M | 201.45M | 171.31M | 92.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 117.50M | 120.69M | 112.57M | 125.22M | 141.57M | 127.86M | 102.89M | 106.34M | 108.40M | 125.91M | 117.56M | 102.41M | 66.44M | 52.20M | 186.42M | 180.40M | 89.28M | 104.70M | 134.74M | 87.96M | 68.77M | 107.07M | 62.06M | 82.30M | 78.60M | 60.05M | 56.16M | 45.56M |
Selling & Marketing | 1.05B | 890.51M | 1.13B | 1.17B | 1.59B | 1.53B | 654.88M | 233.89M | 217.82M | 200.25M | 203.99M | 214.53M | 200.12M | 205.47M | 158.55M | 160.76M | 80.13M | 95.18M | 88.13M | 44.30M | 50.65M | 82.10M | 96.17M | 155.53M | 139.24M | 65.89M | 30.60M | 25.96M |
SG&A | 1.16B | 1.01B | 1.24B | 1.29B | 1.73B | 1.66B | 757.77M | 340.23M | 326.22M | 326.16M | 321.55M | 316.93M | 266.56M | 257.67M | 344.97M | 341.16M | 169.41M | 199.88M | 222.87M | 132.26M | 119.42M | 189.16M | 158.22M | 237.83M | 217.84M | 125.94M | 86.76M | 71.52M |
Other Expenses | -94.06M | 314.98M | 331.95M | 263.66M | 266.98M | -25.75M | -32.48M | 11.31M | 15.18M | 2.17M | 1.38M | -921.55K | 15.58M | -7.91M | -941.97K | -10.49M | 5.21M | -160.29K | -4.77M | 10.95M | 23.48M | 18.90M | -4.74M | 15.37M | 11.67M | -3.45M | -2.43M | 3.67M |
Operating Expenses | 2.14B | 2.14B | 2.38B | 2.10B | 2.45B | 2.27B | 1.31B | 808.70M | 703.49M | 729.06M | 672.46M | 646.82M | 565.78M | 460.01M | 381.05M | 365.95M | 178.61M | 207.23M | 229.72M | 133.08M | 123.54M | 193.03M | 161.73M | 242.05M | 221.73M | 128.93M | 89.61M | 73.64M |
Cost & Expenses | 7.41B | 7.45B | 7.78B | 6.39B | 6.62B | 6.25B | 5.32B | 4.59B | 4.45B | 4.52B | 4.36B | 4.27B | 3.58B | 3.13B | 2.67B | 2.45B | 2.04B | 2.03B | 1.74B | 1.33B | 1.11B | 1.06B | 809.87M | 1.04B | 1.09B | 986.53M | 825.87M | 704.49M |
Interest Income | 9.29M | 13.18M | 15.61M | 19.82M | 10.45M | 11.03M | 9.50M | 8.61M | 13.54M | 23.16M | 30.66M | 31.39M | 18.80M | 8.55M | -0.76 | -0.86 | -0.32 | 7.18M | 5.00M | 3.81M | 4.89M | 4.16M | 6.86M | 4.11M | -0.74 | -0.51 | -0.66 | -0.43 |
Interest Expense | 28.34M | 33.11M | 39.54M | 46.27M | 25.71M | 21.03M | 18.13M | 17.79M | 23.27M | 3.85M | 1.07M | 642.63K | 845.91K | 6.40M | 23.29M | 144.61M | 106.62M | 77.28M | 63.81M | 51.55M | 47.40M | 47.55M | 48.72M | 45.60M | 52.22M | 50.14M | 35.37M | 30.97M |
Depreciation & Amortization | 727.62M | 682.56M | 587.65M | 504.92M | 488.69M | 429.41M | 376.34M | 338.53M | 294.51M | 265.74M | 167.39M | 158.68M | 148.44M | 134.28M | 129.07M | 123.24M | 110.17M | 89.72M | 70.93M | 60.58M | 57.31M | 42.43M | 33.05M | 44.74M | 42.27M | 30.63M | 31.20M | 22.69M |
EBITDA | 1.14B | 1.22B | 1.79B | 1.41B | 913.49M | 895.02M | 695.97M | 897.43M | 511.08M | 479.90M | 705.79M | 1.15B | 1.34B | 1.52B | 1.64B | 1.43B | 276.54M | 257.56M | 227.57M | 130.44M | 114.92M | 121.41M | 102.90M | 100.70M | 129.22M | 137.11M | 89.14M | 59.07M |
EBITDA Ratio | 14.58% | 16.87% | 20.68% | 20.60% | 13.73% | 15.11% | 13.50% | 20.47% | 14.23% | 12.07% | 16.04% | 22.68% | 28.83% | 33.33% | 40.85% | 39.47% | 13.68% | 11.72% | 12.08% | 9.43% | 10.14% | 10.90% | 11.87% | 10.76% | 11.67% | 12.54% | 9.74% | 7.74% |
Operating Income | 380.16M | 687.82M | 1.18B | 882.64M | 409.03M | 469.13M | 333.05M | 552.51M | 179.10M | 272.28M | 554.99M | 1.01B | 1.19B | 1.36B | 1.45B | 1.13B | 84.22M | 93.43M | 102.96M | 11.41M | -7.68M | 16.14M | 27.45M | 20.52M | 61.20M | 62.70M | 57.95M | 36.38M |
Operating Income Ratio | 4.88% | 8.48% | 12.92% | 12.05% | 5.81% | 6.84% | 5.85% | 10.47% | 3.98% | 5.63% | 11.25% | 19.21% | 24.73% | 29.75% | 34.68% | 30.09% | 3.81% | 4.25% | 5.46% | 0.82% | -0.68% | 1.45% | 3.17% | 1.90% | 5.15% | 5.74% | 6.33% | 4.76% |
Total Other Income/Expenses | -16.88M | -9.42M | -25.91M | -31.65M | -11.54M | -25.75M | -32.48M | -8.36M | 13.76M | -62.20M | -7.35M | -15.81M | -5.30M | -22.84M | -29.00M | -189.03M | -78.04M | -113.13M | -56.51M | -41.00M | 17.89M | 15.29M | -6.33M | -10.17M | -7.22M | -8.21M | -2.62M | 383.65K |
Income Before Tax | 363.28M | 491.39M | 1.15B | 850.98M | 397.50M | 443.38M | 300.57M | 540.27M | 192.86M | 210.08M | 547.65M | 995.55M | 1.19B | 1.33B | 1.42B | 1.12B | 88.34M | 90.54M | 92.84M | 18.31M | 10.21M | 31.43M | 21.13M | 22.95M | 60.99M | 57.99M | 55.33M | 36.76M |
Income Before Tax Ratio | 4.66% | 6.05% | 12.64% | 11.61% | 5.64% | 6.46% | 5.28% | 10.23% | 4.29% | 4.35% | 11.10% | 18.91% | 24.62% | 29.25% | 33.99% | 29.81% | 4.00% | 4.12% | 4.93% | 1.32% | 0.90% | 2.82% | 2.44% | 2.13% | 5.13% | 5.31% | 6.05% | 4.81% |
Income Tax Expense | 86.48M | 128.77M | 268.98M | 191.34M | 105.54M | 116.17M | 61.03M | 95.93M | 34.64M | 38.74M | 95.04M | 144.41M | 172.22M | 189.63M | 208.45M | 143.93M | 33.39M | 31.26M | 7.72M | 9.10M | 6.94M | 14.00M | 5.97M | 2.08M | 21.70M | 18.71M | 18.30M | 13.43M |
Net Income | 429.64M | 362.61M | 1.05B | 717.40M | 342.77M | 364.55M | 253.15M | 450.10M | 161.80M | 169.74M | 452.10M | 848.54M | 1.01B | 1.14B | 1.21B | 972.63M | 56.60M | 60.62M | 81.64M | 12.74M | 5.78M | 18.74M | 16.38M | 20.70M | 40.23M | 39.27M | 37.02M | 23.14M |
Net Income Ratio | 5.51% | 4.47% | 11.45% | 9.79% | 4.87% | 5.32% | 4.45% | 8.53% | 3.60% | 3.51% | 9.16% | 16.12% | 20.98% | 25.11% | 29.01% | 25.86% | 2.56% | 2.76% | 4.33% | 0.92% | 0.51% | 1.68% | 1.89% | 1.92% | 3.38% | 3.59% | 4.05% | 3.03% |
EPS | 0.45 | 0.38 | 1.09 | 0.75 | 0.36 | 0.38 | 0.27 | 0.48 | 0.17 | 0.18 | 0.48 | 1.00 | 1.25 | 1.41 | 1.50 | 1.20 | 0.07 | 0.07 | 0.08 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.03 | 0.05 | 0.05 | 0.03 |
EPS Diluted | 0.45 | 0.38 | 1.09 | 0.75 | 0.36 | 0.38 | 0.27 | 0.48 | 0.17 | 0.18 | 0.48 | 1.00 | 1.25 | 1.41 | 1.50 | 1.20 | 0.07 | 0.07 | 0.08 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.03 | 0.05 | 0.05 | 0.03 |
Weighted Avg Shares Out | 954.75M | 958.30M | 958.30M | 958.30M | 958.30M | 959.34M | 936.98M | 936.11M | 936.11M | 943.00M | 941.87M | 848.54M | 809.98M | 811.21M | 809.17M | 810.52M | 783.76M | 810.06M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M |
Weighted Avg Shares Out (Dil) | 954.75M | 958.54M | 958.30M | 958.30M | 958.30M | 959.34M | 937.58M | 937.71M | 951.77M | 943.00M | 941.87M | 848.54M | 809.98M | 811.21M | 809.17M | 810.52M | 783.76M | 810.06M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M | 803.81M |
Source: https://incomestatements.info
Category: Stock Reports